Sequoia Sciences receives fast-track designation for vaccine

Sequoia Sciences has received fast track designation from the Food and Drug Administration for its vaccine to treat urinary tract infections. The designation will expedite the regulatory process for the vaccine for UTIs caused by drug-resistant bacteria. “If approved, the vaccine could change the standard of care for recurrent UTI,” Gary Eldridge, president and CEO of Sequoia Sciences, said in a statement. “Since UTI are a primar y source of sepsis, decreasing recurrent UTI may ultimately…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news